These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6323585)

  • 1. Mononuclear leukocyte cyclic adenosine monophosphate responses in psoriasis are normal.
    Archer CB; Hanson JM; Morley J; MacDonald DM
    J Invest Dermatol; 1984 Apr; 82(4):316-7. PubMed ID: 6323585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema.
    Archer CB; Morley J; MacDonald DM
    Br J Dermatol; 1983 Nov; 109(5):559-64. PubMed ID: 6315045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoceptor function in atopic dermatitis: in vitro and in vivo observations.
    Archer CB; Hanson JM; Morley J; MacDonald DM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():93-7. PubMed ID: 2860767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
    Hall IP; Widdop S; Townsend P; Daykin K
    Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin-dependent desensitization of human monocyte cAMP responses.
    Coffey RG; Alberts VA; Weakland LL
    J Leukoc Biol; 1990 Dec; 48(6):557-64. PubMed ID: 2172433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte and lymphocyte cyclic AMP responses in atopic eczema.
    Parker CW; Kennedy S; Eisen AZ
    J Invest Dermatol; 1977 May; 68(5):302-6. PubMed ID: 192803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.
    Herlin T; Eggert J; Kragballe K; Zachariae H
    Arch Dermatol Res; 1984; 276(5):279-82. PubMed ID: 6091571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ischemia on cyclic adenosine 3',5'monophosphate accumulation in mouse skin.
    Solanki V; Murray AW
    J Invest Dermatol; 1982 Jan; 78(1):48-51. PubMed ID: 6274964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and einephrine by the uninvolved and involved epidermis.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1978 May; 70(5):250-3. PubMed ID: 205616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
    Grewe SR; Chan SC; Hanifin JM
    J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased accumulation of cyclic adenosine 3',5'-monophosphate in "ischemic" skin after 12-0-tetradecanoyl-phorbol-13-acetate treatment.
    Solanki V; Murray AW
    J Invest Dermatol; 1982 Apr; 78(4):264-6. PubMed ID: 6279733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitis.
    Safko MJ; Chan SC; Cooper KD; Hanifin JM
    J Allergy Clin Immunol; 1981 Sep; 68(3):218-25. PubMed ID: 6114971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of ionophores on adenosine 3',5'-monophosphate content in human mononuclear leukocytes.
    Stolc V
    Biochem Pharmacol; 1980 Jul; 29(14):1991-4. PubMed ID: 6250546
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
    Chan SC; Li SH; Hanifin JM
    J Invest Dermatol; 1993 May; 100(5):681-4. PubMed ID: 8388009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Denis D; Riendeau D
    Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.
    Melmon KL; Bourne HR; Weinstein Y; Shearer GM; Kram J; Bauminger S
    J Clin Invest; 1974 Jan; 53(1):13-21. PubMed ID: 4357609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of hormone-stimulated cyclic AMP accumulation in intact human mononuclear leukocytes by blood plasma.
    Motulsky HJ; Smith D; Terman BI; Feldman R
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):329-43. PubMed ID: 3040817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex.
    Donaldson J; Brown AM; Hill SJ
    Biochem Pharmacol; 1988 Feb; 37(4):715-23. PubMed ID: 2829922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.